# OnCo record hibercell (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hibercell/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hibercell" ;
  schema:name "HiberCell"@en ;
  schema:alternateName "HiberCell, Inc."@en, "Biothera Pharmaceuticals"@en ;
  schema:description "HiberCell is a New York biotech working on the biology of dormant, disseminated cancer cells; its yeast beta-glucan immunotherapy imprime PGG, inherited from Biothera, reached late-stage trials with checkpoint inhibitors."@en ;
  schema:url <https://onco.cc/companies/hibercell/>, <https://hibercell.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://hibercell.com>, <https://clinicaltrials.gov/search?lead=HiberCell%2C%20Inc.>, <https://www.wikidata.org/wiki/Q138859693> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/trained-innate-immunity/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .